Inventor
KAUFMANN GUNNAR F
US22 patents
⚠️ This page may combine multiple inventors who share the name “KAUFMANN GUNNAR F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SORRENTO THERAPEUTICS INC
19 patentsUS10058609B2Aug 28, 2018
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC17 citations93
US9676853B2Jun 13, 2017
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC15 citations92
US10584168B2Mar 10, 2020
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC1 citations72
US10472413B2Nov 12, 2019
Anti-infective binding proteins that bind AIP2
SORRENTO THERAPEUTICS INC1 citations72
US10301395B2May 28, 2019
Chemically-locked bispecific antibodies
SORRENTO THERAPEUTICS INC3 citations72
US11878058B2Jan 23, 2024
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US11318202B2May 3, 2022
Antigen binding proteins that bind WISP1
SORRENTO THERAPEUTICS INC0 citations62
US11242391B2Feb 8, 2022
Antigen binding proteins that bind PD-1
SORRENTO THERAPEUTICS INC0 citations62
US11027012B2Jun 8, 2021
Antigen binding proteins that bind PD-L1
SORRENTO THERAPEUTICS INC0 citations62
US10272154B2Apr 30, 2019
Antigen binding proteins that bind WISP1
SORRENTO THERAPEUTICS INC1 citations62
US11267905B2Mar 8, 2022
Chemically-locked bispecific antibodies
SORRENTO THERAPEUTICS INC0 citations61
US9631009B2Apr 25, 2017
Anti-infective binding proteins that bind AIP2
SORRENTO THERAPEUTICS INC1 citations61
US10435479B2Oct 8, 2019
Chemically-locked bispecific antibodies
SORRENTO THERAPEUTICS INC1 citations60
US10925968B2Feb 23, 2021
Cell internalizing compounds
SORRENTO THERAPEUTICS INC0 citations58
US12180294B2Dec 31, 2024
Dimeric antigen receptors
SORRENTO THERAPEUTICS INC0 citations54
US9879069B2Jan 30, 2018
Antibody therapeutics that bind OprF
SORRENTO THERAPEUTICS INC0 citations52
US10799598B2Oct 13, 2020
Disulfide bridging conjugates
SORRENTO THERAPEUTICS INC0 citations51
US10774135B2Sep 15, 2020
Variant antibodies that bind AIP2
SORRENTO THERAPEUTICS INC0 citations50
US10583193B2Mar 10, 2020
Cell penetrating peptide inhibitors of p53-MDM2 interaction
SORRENTO THERAPEUTICS INC0 citations40